All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
NKTR / Nektar Therapeutics Call
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
|
|
|
|
|
|
|
|
GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc Call
|
|
|
|
|
|
|
|
ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
QTRX / Quanterix Corporation
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
US28249H1041 / Eidos Therapeutics, Inc.
|
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
ITRM / Iterum Therapeutics plc
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
TBIO / Telesis Bio, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
INSP / Inspire Medical Systems, Inc.
|
|
|
|
|
|
|
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
TCDA / Tricida Inc
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RUBY / Rubius Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVRO / AVROBIO, Inc.
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc. Call
|
|
|
|
|
|
|
|
GNFTF / Genfit S.A.
|
|
|
|
|
|
|
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation Call
|
|
|
|
|
|
|
|
MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|